396
Participants
Start Date
February 6, 2017
Primary Completion Date
September 10, 2018
Study Completion Date
September 25, 2018
Liraglutide 3.0 mg
Injected subcutaneously (s.c., under the skin) once daily
Placebo
Injected subcutaneously (s.c., under the skin) once daily
Novo Nordisk Investigational Site, Albany
Novo Nordisk Investigational Site, Falkensee
Novo Nordisk Investigational Site, Hamburg
Novo Nordisk Investigational Site, Wilmington
Novo Nordisk Investigational Site, Roswell
Novo Nordisk Investigational Site, Jacksonville
Novo Nordisk Investigational Site, Plantation
Novo Nordisk Investigational Site, Istanbul
Novo Nordisk Investigational Site, Istanbul
Novo Nordisk Investigational Site, Istanbul
Novo Nordisk Investigational Site, Istanbul
Novo Nordisk Investigational Site, Haifa
Novo Nordisk Investigational Site, Birmingham
Novo Nordisk Investigational Site, Izmir
Novo Nordisk Investigational Site, Bologna
Novo Nordisk Investigational Site, Louisville
Novo Nordisk Investigational Site, Kfar Saba
Novo Nordisk Investigational Site, Guadalajara
Novo Nordisk Investigational Site, Essen
Novo Nordisk Investigational Site, Münster
Novo Nordisk Investigational Site, Petah Tikva
Novo Nordisk Investigational Site, Tel Litwinsky
Novo Nordisk Investigational Site, Minneapolis
Novo Nordisk Investigational Site, Butte
Novo Nordisk Investigational Site, Chicago
Novo Nordisk Investigational Site, Tel Aviv
Novo Nordisk Investigational Site, Monterrey
Novo Nordisk Investigational Site, Saint Ingbert-Oberwürzbach
Novo Nordisk Investigational Site, Rehlingen-Siersburg
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Austin
Novo Nordisk Investigational Site, Austin
Novo Nordisk Investigational Site, Napoli
Novo Nordisk Investigational Site, Palermo
Novo Nordisk Investigational Site, Jerusalem
Novo Nordisk Investigational Site, Fresno
Novo Nordisk Investigational Site, Concord
Novo Nordisk Investigational Site, Honolulu
Novo Nordisk Investigational Site, North Dartmouth
Novo Nordisk Investigational Site, Winchester
Novo Nordisk Investigational Site, Calgary
Novo Nordisk Investigational Site, Edmonton
Novo Nordisk Investigational Site, Halifax
Novo Nordisk Investigational Site, Hamilton
Novo Nordisk Investigational Site, London
Novo Nordisk Investigational Site, Toronto
Novo Nordisk Investigational Site, Waterloo
Novo Nordisk Investigational Site, Québec
Novo Nordisk Investigational Site, Dresden
Novo Nordisk Investigational Site, Leipzig
Novo Nordisk Investigational Site, Rome
Novo Nordisk Investigational Site, Ankara
Novo Nordisk Investigational Site, Antalya
Lead Sponsor
Novo Nordisk A/S
INDUSTRY